Ovid Therapeutics Inc. · NASDAQ:OVID
Ra Capital Management, L.P. reported a 9.90% stake in Ovid Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Ovid Therapeutics Inc., 19,549,271 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 19,549,271
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 19,549,271 |
| Peter Kolchinsky | 9.90% | 19,549,271 |
| Rajeev Shah | 9.90% | 19,549,271 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 19,549,271 |
Source
Related
- Ovid Therapeutics Inc.
- Ra Capital Management, L.P.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Dec 18, 2025
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026